147 related articles for article (PubMed ID: 17264427)
1. Insulin resistance in chronic hepatitis B and C.
Mohammad Alizadeh AH; Fallahian F; Alavian SM; Ranjbar M; Hedayati M; Rahimi F; Khedmat H; Etemadi A; Zali MR; Azizi F
Indian J Gastroenterol; 2006; 25(6):286-9. PubMed ID: 17264427
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
[TBL] [Abstract][Full Text] [Related]
7. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
[TBL] [Abstract][Full Text] [Related]
9. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.
Tsochatzis E; Papatheodoridis GV; Manolakopoulos S; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2009; 44(6):752-9. PubMed ID: 19296398
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
[TBL] [Abstract][Full Text] [Related]
13. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
14. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
[TBL] [Abstract][Full Text] [Related]
15. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.
Khattab MA; Abdel-fattah ME; Eslam M; Abdelaleem A; Abdelaleem RA; Shatat M; Ali A; Hamdy L; Tawfek H
J Clin Gastroenterol; 2010; 44(10):707-12. PubMed ID: 20195166
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C.
Sturm N; Marlu A; Arvers P; Zarski JP; Leroy V
Liver Int; 2013 Mar; 33(3):428-38. PubMed ID: 23402612
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
